首页 | 本学科首页   官方微博 | 高级检索  
检索        

乳腺癌保乳术后放疗疗效和美观效果
引用本文:金冶宁,王雅杰,张晓青,孟岩,李荣清,施俊义.乳腺癌保乳术后放疗疗效和美观效果[J].中华放射肿瘤学杂志,2005,14(3):177-180.
作者姓名:金冶宁  王雅杰  张晓青  孟岩  李荣清  施俊义
作者单位:1. 上海第二医科大学附属瑞金医院肿瘤放化疗科
2. 200025,上海第二军医大学附属长海医院肿瘤科
3. 200025,上海第二军医大学附属长海医院放疗科
4. 200025,上海第二军医大学附属长海医院普外科
基金项目:上海市卫生局“百人计划”基金资助项目 (0 96)
摘    要:目的 观察乳腺癌保乳术后放疗的疗效和美观效果。方法 保乳术后全乳外照射和瘤床加量共10 9例,79例除应用高剂量率插植技术T1期肿瘤用单排插植,针距为1.5cm ,T2期以上肿瘤用双排或三排插植;针距间单次剂量(DB) 10~12Gy ,靶区周边剂量为85 %DB]外,其中4 8例还经组织间插植加量放疗;30例除采用电子线常规外照射15Gy外,其中2 7例还经电子线外照加量放疗。全乳照射应用6MV直线加速器,采用双切线半野照射技术,靶区剂量为4 5~5 2Gy(平均4 8.6Gy)。采用医生评分与患者问卷方法评价美观效果。结果 5年生存率为93.8% ,局部复发率为6 .5 %。全组无放射性溃疡发生,5例出现位于插植针孔周围急性皮肤炎症。在经临床随访体检的75例中,医生打分和患者自评满意度为优的比例分别占87%和81% (P >0 .0 5 )。两组满意度医生总评为优的患者比例分别为81.2 %和85 .2 % (P >0 .0 5 )。结论 乳腺癌保乳术后放疗可降低术后复发率,并发症少。不同的瘤床加量放疗方法不影响美观满意度。

关 键 词:美观效果  术后放疗  乳腺癌  疗效  半野照射技术  急性皮肤炎症  组织间插植  常规外照射  直线加速器  5年生存率  局部复发率  放射性溃疡  术后复发率  美观满意度  保乳术后  高剂量率  单次剂量  周边剂量  靶区剂量  方法评价  临床随访
修稿时间:2004年3月12日

Clinical outcome and cosmetic results of conservative surgery plus radiation therapy in early stage breast cancer patients
Jin Ye-ning,WANG Ya-jie,ZHANG Xiao-qing,MENG Yan,LI Rong-qing,SHI Jun-yi.Clinical outcome and cosmetic results of conservative surgery plus radiation therapy in early stage breast cancer patients[J].Chinese Journal of Radiation Oncology,2005,14(3):177-180.
Authors:Jin Ye-ning  WANG Ya-jie  ZHANG Xiao-qing  MENG Yan  LI Rong-qing  SHI Jun-yi
Abstract:Objective To evaluate the clinical outcome and cosmetic results in early stage breast cancer patients treated with conservative surgery plus radia tion therapy. Methods From May 1995 to December 2002, 109 such patients were s o treated. The post-operative radiotherapy consisted of whole-breast 6?MV lin ear accelerator irradiation with two tangential half-fields to a total dose of 45- 52 ?Gy (mean 48.6?Gy), followed by a boost irradiation to the tumor bed. Among th em, 79 patients received 10-12 ?Gy(DB) boost by interstitial implantation brachyth era py ( 192 Ir HDR , Nucletron ), with single plane implantation for T1 a nd double pl ane implantation for T2 tumor. Thirty patients received 15?Gy boost by electron b eam. Adjuvant/concurrent chemotherapy (CMF or CEF) and hormonotherapy were also used according to the patients' clinical characteristics. The cosmetic results w ere scored by both the doctor and the patients. Results The overall actuarial 5-year survival was 93.8%, with local recurrence of 6.5%. No radiation-induced ulcer was observed in the breast except for acute inflammation at skin pinholes in 5 patients treated by interstitial implant brachytherapy. Among the 75 patie nts who had had breast examination, cosmetic result scored as good by patient a nd doctor were 81% and 87%, respectively. The good rate assessed by doctor in br achytherapy boost group and electron beam boost group were 81.2% (39/48) and 85. 2% (23/27), There was no significant difference between these two boost techniqu es (P>0.05). Conclusions Tumor bed boost irradiation by either brachytherapy or electron beam technique can provide satisfactory local control in early brea st cancer treated with conservative surgery plus radiotherapy without increasing the side effects. There is no significant difference in cosmetic result between these two boost techniques.
Keywords:Breast neoplasms/radiotherapy  Breast neoplasms/brachytherapy  Prognosis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号